Frontiers in Oncology (Apr 2022)
Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
- Xu Zhang,
- Xu Zhang,
- Xu Zhang,
- Jie Wang,
- Jie Wang,
- Jie Wang,
- Yifeng Wang,
- Yifeng Wang,
- Guanzheng Liu,
- Huan Li,
- Jiefeng Yu,
- Runqiu Wu,
- Jun Liang,
- Rutong Yu,
- Rutong Yu,
- Xuejiao Liu,
- Xuejiao Liu
Affiliations
- Xu Zhang
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Xu Zhang
- Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Xu Zhang
- The Graduate School, Nanjing Medical University, Nanjing, China
- Jie Wang
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Jie Wang
- Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Jie Wang
- Department of Neurosurgery, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Yifeng Wang
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Yifeng Wang
- Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Guanzheng Liu
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Huan Li
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Jiefeng Yu
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Runqiu Wu
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Jun Liang
- Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Rutong Yu
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Rutong Yu
- Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- Xuejiao Liu
- Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China
- Xuejiao Liu
- Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- DOI
- https://doi.org/10.3389/fonc.2022.911817
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- glioblastoma multiforme
- glioblastoma stem-like cells
- maternal embryonic leucine-zipper kinase
- OTSSP167
- targeted therapy
